COSCIENS Biopharma Inc. Description Of Expected Volatility Share Options Granted
COSCIENS Biopharma Inc. (CSCIF) reported Description Of Expected Volatility Share Options Granted of 65.00% for the 6-month period ending 2024-06-30, per its 6-K filed 2024-08-13.
Financial Statements › Notes
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted · last filed 2024-11-12
- COSCIENS Biopharma Inc. description of expected volatility share options granted for the quarter ending 2023-03-31 was 104.46%, a 9.75% decline year-over-year.
- COSCIENS Biopharma Inc. description of expected volatility share options granted for the quarter ending 2022-03-31 was 115.75%.
| Period end | Description Of Expected Volatility Share Options Granted 3 month | Description Of Expected Volatility Share Options Granted 3 month as first filed | Description Of Expected Volatility Share Options Granted 6 month | Description Of Expected Volatility Share Options Granted 6 month as first filed | Description Of Expected Volatility Share Options Granted 9 month | Description Of Expected Volatility Share Options Granted 9 month as first filed | Description Of Expected Volatility Share Options Granted 12 month |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | 65.00% 6-K · filed 2024-08-13 | ||||||
| 2023-12-31 | 104.46% 20-F/A · filed 2024-07-17 | ||||||
| 2023-09-30 | 65.00% 6-K · filed 2024-11-12 | 104.46% 6-K · filed 2023-11-09 | |||||
| 2023-06-30 | 104.46% 6-K · filed 2023-08-09 | ||||||
| 2023-03-31 | 104.46% 6-K · filed 2023-05-09 | ||||||
| 2022-12-31 | 115.75% 20-F/A · filed 2024-07-17 | ||||||
| 2022-09-30 | 115.75% 6-K · filed 2023-11-09 | ||||||
| 2022-06-30 | 115.75% 6-K · filed 2023-08-09 | 115.80% 6-K/A · filed 2022-08-04 | |||||
| 2022-03-31 | 115.75% 6-K · filed 2023-05-09 | 115.80% 6-K · filed 2022-05-11 | |||||
| 2021-12-31 | 115.80% 20-F/A · filed 2024-07-17 | ||||||
| 2020-12-31 | 112.50% 20-F/A · filed 2024-02-15 | ||||||
| 2019-12-31 | 110.02% 20-F · filed 2022-03-29 | ||||||
| 2018-12-31 | 129.23% 20-F · filed 2020-03-31 |